| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |